Form 4: BBBY Chief Accounting Officer Reports Stock Transactions

Bed Bath & Beyond's Chief Accounting Officer, Leah R. Putnam, reported the vesting of restricted stock units, a sale for tax withholding, and the acquisition of common stock warrants.

Summary

• Leah R. Putnam, Chief Accounting Officer of Bed Bath & Beyond, Inc., reported transactions on November 15, 2025.
• Acquired 1,186 shares of common stock at a price of $0.0001 per share through the vesting of restricted stock units.
• Disposed of 289 shares of common stock at a price of $6.03 per share for tax withholding purposes.
• Beneficial ownership of common stock following these transactions is 3,077 shares.
• Acquired 218 common stock warrants, which were originally issued on October 7, 2025, with an exercise price of $15.50 per warrant and an expiration date of October 7, 2026.
• Beneficial ownership of derivative securities includes 26,906 restricted stock units and 218 common stock warrants.

Sentiment

Score: 5

Explanation: Neutral. The filing reports routine insider transactions including RSU vesting (positive for insider), tax withholding (routine), and warrant acquisition (potential upside but high exercise price relative to current stock value). No significant positive or negative operational news is conveyed.

Positives

• Vesting of 1,186 restricted stock units, increasing direct common stock ownership for the reporting person.
• Acquisition of 218 common stock warrants, providing potential future upside if the stock price exceeds the exercise price.

Negatives

• Disposition of 289 shares of common stock at $6.03 per share for tax withholding purposes, reducing direct common stock holdings.
• The warrant exercise price of $15.50 is significantly higher than the stock price at which shares were disposed ($6.03), indicating the stock needs substantial appreciation for the warrants to be in-the-money.

Risks

• The exercisability of the common stock warrants is contingent upon a registration statement on Form S-3 being declared effective by the SEC, introducing a potential delay or uncertainty.
• The high exercise price of $15.50 for the warrants means they may expire worthless if the common stock price does not rise above this level by October 7, 2026.

Future Outlook

Restricted stock units are scheduled to vest in a second equal installment on November 15, 2026. The acquired warrants will become exercisable upon the SEC declaring a Form S-3 registration statement effective, and can be exercised at any time thereafter through their expiration on October 7, 2026.

Industry Context

This filing is a standard insider transaction report and does not provide information directly related to broader industry trends or competitors.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency into insider ownership changes and potential future stock sales/exercises. The high warrant exercise price might be a point of concern if the stock is trading significantly lower.
• Employees: The vesting of RSUs is a standard compensation event for executives.

Next Steps

• Second installment of restricted stock units to vest on November 15, 2026.
• Warrants to become exercisable upon the SEC declaring a Form S-3 registration statement effective.

Key Dates

Keywords

Bed Bath & Beyond, BBBY, Form 4, Insider Trading, Restricted Stock Units, Warrants, Stock Transactions, Chief Accounting Officer, Leah R. Putnam